GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xencor Inc (FRA:XE9) » Definitions » Total Long-Term Liabilities

Xencor (FRA:XE9) Total Long-Term Liabilities : €163.2 Mil (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Xencor Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Xencor's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was €163.2 Mil.

Xencor Total Long-Term Liabilities Historical Data

The historical data trend for Xencor's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xencor Total Long-Term Liabilities Chart

Xencor Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.01 30.06 51.85 210.12 181.92

Xencor Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 177.25 170.52 153.86 181.92 163.15

Xencor Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Xencor Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Xencor's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Xencor Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xencor Inc (FRA:XE9) » Definitions » Total Long-Term Liabilities
Comparable Companies
RGLS COGT MNMD BCYC SION STOK KALV BCAX RLAY TYRA VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
XNCR:USA XE9:Germany
Address
465 North Halstead Street, Suite 200, Pasadena, CA, USA, 91107
Website
https://www.xencor.com
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Xencor Headlines

No Headlines